Oesophageal Carcinoma

  • Damian McManusEmail author


Oesophageal Carcinoma: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM8 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the more common malignancies that are encountered at this site in diagnostic practice.


Adenocarcinoma Squamous cell carcinoma TNM8 Barrett’s metaplasia Siewert classification Dysplasia Immunohistochemistry 


  1. Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R, On behalf of the Association of Upper Gastrointestinal Surgeons of Great Britain and Northern Ireland, the British Society of Gastroenterology and the British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60:1449–72.CrossRefGoogle Scholar
  2. Barr H. The pathological implications of surveillance, treatment and surgery for Barrett’s oesophagus. Curr Diagn Pathol. 2003;9:242–51.CrossRefGoogle Scholar
  3. Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, et al. Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049–57.Google Scholar
  4. Bogomeletz WV. Early squamous cell carcinoma of oesophagus. Curr Diagn Pathol. 1994;1:212–5.CrossRefGoogle Scholar
  5. Bosman FT, Carneiro F. GI WHO classification of tumours. Digestive system tumours. 5th ed.; 2019.Google Scholar
  6. Chandrasama P, Wickramasinghe K, Ma Y, DeMeester T. Adenocarcinomas of the distal esophagus and “gastric cardia” are predominantly esophageal carcinomas. Am J Surg Pathol. 2007;31:569–75.CrossRefGoogle Scholar
  7. Coad RA, Shepherd NA. Barrett’s oesophagus: definition, diagnosis and pathogenesis. Curr Diagn Pathol. 2003;9:218–27.CrossRefGoogle Scholar
  8. Cotton P, Williams C. Practical gastrointestinal endoscopy. 4th ed. London: Blackwell Science; 1996.Google Scholar
  9. Curvers WL, ten Kate FJ, Krishnadath KK, Visser M, Elzer B, Baak LC, Bohmer C, Mallant-Hent RC, van Oijen A, Naber AH, Scholten P, Busch OR, Blaauwgeers HG, Meijer GA, Bergman JJ. Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. Am J Gastroenterol. 2010 Jul;105:1523–30.CrossRefGoogle Scholar
  10. Day DW, Jass JR, Price AB, Shepherd NA, Sloan JM, Talbot IC, Warren BF, Williams GT. Morson and Dawson’s Gastrointestinal Pathology. 4th ed. Oxford: Blackwell Sciences; 2003.CrossRefGoogle Scholar
  11. Deshpande A, Nelson D, Corless CL, Deshpande V, O’Brien MJ. Leiomyoma of the gastrointestinal tract with interstitial cells of Cajal: A mimic of gastrointestinal stromal tumor. Am J Surg Pathol. 2014;38:72–7.CrossRefGoogle Scholar
  12. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O’Donovan M, Bird-Lieberman E, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de Caestecker J, British Society of Gastroenterology. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.CrossRefGoogle Scholar
  13. Flejou J-F, Svrcek M. Barrett’s oesophagus - a pathologist’s view. Histopathology. 2007;50:3–14.CrossRefGoogle Scholar
  14. Galmiche JP, Pallone F. Barrett’s oesophagus and oesophageal adenocarcinoma. Gut. 2005;54:i1–i42.Google Scholar
  15. Hage M, Siersema PD, van Dekken H. Oesophageal pathology following ablation of Barrett’s mucosa. Curr Diagn Pathol. 2006;12:127–35.CrossRefGoogle Scholar
  16. Jankowski J, Barr H, Wang K, Delaney B. Diagnosis and management of Barrett’s oesophagus. BMJ. 2010;341:597–602.CrossRefGoogle Scholar
  17. Lagergren J, Lagergren P. Oesophageal cancer. BMJ. 2010;341:1207–11.CrossRefGoogle Scholar
  18. Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Atlas of Tumor pathology. 3rd series. Fascicle 18. Washington: AFIP; 1996.Google Scholar
  19. Lin DC, Dinh HQ, Xie JJ, Mayakonda A, Silva TC, Jiang YY, Ding LW, He JZ, Xu XE, Hao JJ, Wang MR, Li C, Xu LY, Li EM, Berman BP, Phillip Koeffler H. Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas. Gut. 2018 Oct;67:1769–79.CrossRefGoogle Scholar
  20. Logan RPH, Harris A, Misciewicz JJ, Baron JH. ABC of the upper gastrointestinal tract. London: BMJ Books; 2002.Google Scholar
  21. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, et al. Pathologic assessment of tumour regression after preoperative chemoradiotherapy of oesophageal carcinoma. Cancer. 1994;73:2680–96.CrossRefGoogle Scholar
  22. Moyes LH, Going JJ. Still waiting for predictive biomarkers in Barrett’s oesophagus. J Clin Pathol. 2011;64:742–50.CrossRefGoogle Scholar
  23. Odze RD, Goldblum JR. Surgical pathology of the gi tract, liver, biliary tract and pancreas. 2nd ed. Amsterdam: Saunders Elsevier; 2009.Google Scholar
  24. Pech O, May A, Rabenstein T, Ell C. Endoscopic resection of early oesophageal cancer. Gut. 2007;56:1625–34.CrossRefGoogle Scholar
  25. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251–5.CrossRefGoogle Scholar
  26. The Royal College of Pathologists. Cancer Datasets (Oesophageal Carcinoma, Gastric Carcinoma, Carcinomas of the Pancreas, ampulla of Vater and Common Bile Duct, Colorectal Cancer, Gastrointestinal Stromal Tumours (GISTs), Liver Resection Specimens and Liver Biopsies for Primary and Metastatic Carcinoma, Endocrine Tumours of the Gastrointestinal Tract including Pancreas) and Tissue Pathways (Gastrointestinal and Pancreatobiliary Pathology, Liver Biopsies for the Investigation of Medical Disease and for Focal Liver Lesions); (n.d.).
  27. Wang LM, Sheahan K. Pathological assessment of post-treatment gastrointestinal and hepatic resection specimens. Curr Diagn Pathol. 2007;13:222–31.CrossRefGoogle Scholar
  28. Yantis RK, Odze RD. Neoplastic precursor lesions of the upper gastrointestinal tract. Diagn Histopathol. 2008;14:437–52.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Institute of Pathology, Royal Victoria HospitalBelfastUK

Personalised recommendations